Earlier studies have shown that IL7R is extremely low in bone marrow [21], which corroborates with this paper, so the presence of a significant increase in bone marrow of AML patients combined with the results of ROC analysis (AUC = 0.993) suggests that IL7R is a suitable bone marrow biomarker for AML diagnosis. Here, IL7R is linked to acute myeloid leukemia.